Learn More
BACKGROUND BRCA1 and BRCA2 are the two major genes responsible for the breast and ovarian cancers that cluster in families with a genetically determined predisposition. However, regardless of the mutation detection method employed, the percentage of families without identifiable alterations of these genes exceeds 50%, even when applying stringent criteria(More)
Brain metastases are a serious relatively common complication of breast cancer. We evaluated prognostic factors for survival after diagnosis of brain metastases from breast cancer in a contemporary cohort of patients. Patients diagnosed with breast cancer brain metastases at our institution between 1999 and March 2016 were evaluated. Overall survival was(More)
Sir, We read with great interest the article by Arnould et al (2006). In their study, they investigated by immunohistochemistry (IHC) immune cell response during neoadjuvant primary systemic therapy with trastuzumab and docetaxel in patients with IHC 3 þ HER2-positive primary breast cancer. Trastuzumab treatment was associated with significantly increased(More)
  • 1